Thank you for your interest in Bioengineering Insights 2009. The event was a huge success and we are grateful to all speakers, sponsors, and attendees for their participation.
Translating engineering and science into biomedical and biotechnological applications.
Opening Keynote: Lee Hood
Co-founder, Institute for Systems Biology (Seattle, Washington)
Dr. Hood’s research has focused on fundamental biology (immunity, evolution, genomics) and on bringing engineering to biology through the development of five instruments—the DNA and protein sequencers and synthesizers and the ink-jet oligonucleotide synthesizer (to make DNA arrays)—for deciphering the various types of biological information (DNA, RNA, proteins and systems). Those instruments constitute the technological foundation for modern molecular biology and genomics. The DNA sequencer in particular revolutionized genomics by allowing the rapid automated sequencing of DNA... more
Dr. Hood’s research has focused on fundamental biology (immunity, evolution, genomics) and on bringing engineering to biology through the development of five instruments—the DNA and protein sequencers and synthesizers and the ink-jet oligonucleotide synthesizer (to make DNA arrays)—for deciphering the various types of biological information (DNA, RNA, proteins and systems). Those instruments constitute the technological foundation for modern molecular biology and genomics. The DNA sequencer in particular revolutionized genomics by allowing the rapid automated sequencing of DNA... more
Afternoon Keynote: Jamey Marth
Director, UC Santa Barbara-Burnham Center for Nanomedicine
Dr. Marth joined the faculty in UC Santa Barbara’s Department of Molecular, Cellular, and Developmental Biology, as well as the faculty of the Burnham Institute for Medical Research, on July 1, 2009. His research laboratory is renowned in the interdisciplinary application of molecular and cellular biology to discovering the origins of grievous disease. Dr. Marth is also co-founder and the Chair of the Scientific Advisory Board of Abaron Biosciences, Inc., an early-stage biotechnology company that is focused on developing a new class of therapeutics for the prevention and treatment of grievous... more
Dr. Marth joined the faculty in UC Santa Barbara’s Department of Molecular, Cellular, and Developmental Biology, as well as the faculty of the Burnham Institute for Medical Research, on July 1, 2009. His research laboratory is renowned in the interdisciplinary application of molecular and cellular biology to discovering the origins of grievous disease. Dr. Marth is also co-founder and the Chair of the Scientific Advisory Board of Abaron Biosciences, Inc., an early-stage biotechnology company that is focused on developing a new class of therapeutics for the prevention and treatment of grievous... more
Santa Barbara
Held in beautiful downtown Santa Barbara at the prestigious Fess Parker’s DoubleTree Resort. Only ten minutes from the UC Santa Barbara campus and a stone's throw from the beach.
Only $159.00 per room for conference attendees— stay longer for the same price... more
Only $159.00 per room for conference attendees— stay longer for the same price... more
Thank you to our sponsors:
Campus Sponsors:
 |
 |
 |
 |
Related Convergence Articles
Bioengineering research teams at UCSB are developing some of the world’s most advanced and sophisticated detection and diagnostic techniques.
Second hand smoke has been implicated in a host of health problems... It hasn’t, however, been fully understood how the damage to the lungs is done.
Vaccines are one of the great successes of modern medicine—they’ve saved millions of lives by preventing infections by a wide variety of pathogens.
